Quick Answer
PETMED EXPRESS INC reported Total Revenue of $226.97 million for the year ending 2025.
- PETMED EXPRESS INC showed a decrease of -17.2% in Total Revenue from 2024 to 2025.
- This data is from PETMED EXPRESS INC's annual report (Form 10-K), filed with the SEC on October 14, 2025.
- XBRL data for this metric is available from 2016 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2016: $72.49 million | Q3 2016: $60.79 million | Q4 2016: $52.87 million | Q1 2017: $63.03 million | Q2 2017: $79.66 million | Q3 2017: $66.71 million | Q4 2017: $60.11 million | Q1 2018: $67.32 million | Q2 2022: $67.39 million | Q3 2022: $63.16 million | Q4 2022: $57.24 million | Q2 2023: $75.91 million | Q3 2023: $69.46 million | Q4 2023: $63.67 million | Q2 2024: $66.21 million | Q3 2024: $58.04 million | Q4 2024: $51.96 million | Q2 2025: $51.18 million | Q3 2025: $44.36 million | Q4 2025: $40.66 million.
- Over the full 6 years of available data (2016 to 2025), PETMED EXPRESS INC's Total Revenue has declined by 3.3%.
- Historical annual values: Fiscal year 2025: $226.97 million | Fiscal year 2024: $274.10 million | Fiscal year 2023: $247.57 million | Fiscal year 2018: $273.80 million | Fiscal year 2017: $249.18 million | Fiscal year 2016: $234.68 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: